Oxaliplatin is embryotoxic in rats. Oxaliplatin may cause fetal harm when administered to pregnant women. The patient should be apprised of potential hazard to the fetus and potential risk for loss of the pregnancy if there is exposure to oxaliplatin during pregnancy.
It is not known whether oxaliplatin is excreted in human milk or not. Caution should be exercised when oxaliplatin is administered to a nursing woman as many drugs are excreted in human milk.